母体年龄是否影响整倍体胚胎移植后辅助生殖技术的成功率?一项系统综述与荟萃分析
该系统综述与荟萃分析纳入7项研究共11335例整倍体胚胎移植,比较不同母体年龄对辅助生殖技术结局的影响。结果显示,<35岁女性持续妊娠率或活产率高于≥35岁女性(OR 1.29,95%CI 1.07-1.54),种植率也更高(OR 1.22,95%CI 1.12-1.32)。作者认为,母体年龄增加与辅助生殖技术成功率下降相关,且不依赖于胚胎倍性。
要点
- 整倍体胚胎移植后,<35岁女性持续妊娠率或活产率高于≥35岁女性(OR 1.29,95%CI 1.07-1.54)。
- <35岁女性种植率高于≥35岁女性(OR 1.22,95%CI 1.12-1.32)。
- 母体年龄增加与辅助生殖技术成功率下降相关,且不依赖于胚胎倍性。
核心结论
- 母体年龄增加与辅助生殖技术成功率下降相关,且不依赖于胚胎倍性。
- 该信息有助于在启动非整倍体植入前遗传学检测程序前对患者进行适当咨询。
研究设计与样本
- 系统综述与荟萃分析,检索ScienceDirect、PubMed、Scopus、Embase、Cochrane图书馆、Clinicaltrials.gov、EU Clinical Trials Register及世界卫生组织国际临床试验注册平台,自建库至2021年11月。
- 纳入观察性研究和随机对照研究,共7项研究,n=11335例整倍体胚胎辅助生殖技术移植。
- 主要结局为<35岁与≥35岁女性整倍体胚胎移植后持续妊娠率或活产率(OPR/LBR),次要结局包括种植率和流产率。
- 采用改良版纽卡斯尔-渥太华量表评估研究质量,采用推荐分级的评估、制定与评价工作组方法学评估证据体。
- PROSPERO注册号:CRD42021289760。
主要发现
- <35岁女性持续妊娠率或活产率高于≥35岁女性(OR 1.29,95%CI 1.07-1.54;I²=40%),风险差为0.06(95%CI 0.02-0.09)。
- <35岁女性种植率高于≥35岁女性(OR 1.22,95%CI 1.12-1.32;I²=0%)。
- 与35-37岁、38-40岁或41-42岁女性相比,<35岁女性持续妊娠率或活产率也显著更高。
- 比例荟萃分析中可观察到年龄与持续妊娠率或活产率之间的梯度关系,尤其在限制于低偏倚风险研究时。
关键数值与推荐
- 主要结局比较<35岁与≥35岁女性整倍体胚胎移植后持续妊娠率或活产率(OPR/LBR)。
- 次要结局包括种植率和流产率,并计划进行亚组和敏感性分析以探索研究间不一致的来源。
临床怎么用
- 作者认为,该信息有助于在启动非整倍体植入前遗传学检测程序前对患者进行适当咨询。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Maternal age-related embryo aneuploidy is considered the most significant limiting factor for a favorable outcome after assisted reproduction technology (ART) procedures. Thus, preimplantation genetic testing for aneuploidies has been proposed as a strategy to genetically evaluate embryos before transfer to the uterus. However, whether embryo ploidy justifies all the aspects of age-related fertility decline remains controversial. OBJECTIVE: To investigate the effect of different maternal ages on ART success rates after transfer of euploid embryos. DATA SOURCES: ScienceDirect, PubMed, Scopus, Embase, the Cochrane library, Clinicaltrials.gov, EU Clinical Trials Register, and World Health Organization International Clinical Trials Registry were searched from inception until November 2021 using combinations of relevant keywords. STUDY SELECTION AND SYNTHESIS: Observational and randomized controlled studies were included if they investigated the impact of maternal age on ART outcomes after the transfer of euploid embryos and reported frequencies of women achieving ongoing pregnancy or live birth. MAIN OUTCOMES: The ongoing pregnancy rate or live birth rate (OPR/LBR) after euploid embryo transfer comparing women <35 vs. women ≥35 years old was the primary outcome. Secondary outcomes included implantation rate and miscarriage rate. Subgroup and sensitivity analyses were also planned to explore the sources of inconsistency among studies. The quality of studies was assessed using a modified version of the Newcastle-Ottawa Scale, and body of evidence was evaluated using the Grading of Recommendations Assessment Development and Evaluation working group methodology. RESULTS: A total of 7 studies were included (n = 11,335 ART embryo transfers of euploid embryos). A higher OPR/LBR (odds ratio, 1.29; 95% confidence interval [CI], 1.07-1.54; I2 = 40%) in women aged <35 years than in women ≥35 with a risk difference equal to 0.06 (95% CI, 0.02-0.09) was found. In line, implantation rate was higher in the youngest group (odds ratio, 1.22; 95% CI, 1.12-1.32; I2 = 0%). A statistically significant higher OPR/LBR was also found comparing women aged <35 to women 35-37, 38-40, or 41-42. A gradient relationship between age and OPR/LBR could be observed in proportion meta-analysis, especially if restricted to studies with low risk of bias. CONCLUSION AND RELEVANCE: Increasing maternal age is associated with a decline in ART success rates independent of embryo ploidy. This message contributes to an appropriate patient's counseling before starting preimplantation genetic testing for aneuploidies procedures. PROSPERO REGISTRATION NUMBER: CRD42021289760.
引用
- Vitagliano A, Paffoni A, Viganò P, et al. Does maternal age affect assisted reproduction technology success rates after euploid embryo transfer? A systematic review and meta-analysis. Fertil Steril. 2023. PMID: 36878347. doi:10.1016/j.fertnstert.2023.02.036
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。